
Precision BioSciences, Inc.
USD6.04
-0.28 (-4.43%)
CEO
Juli Blanche
IPO Date
2019-03-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$6.17
Prev. Close
$6.32
Day Low
$6.00
Day High
$6.35
52W Low
$3.53
52W High
$8.82
Market Cap
$0.08B
Volume
0.23M
Precision BioSciences Doses First Patient in Phase 1 Allogeneic CAR T Clinical Trial of PBCAR19B Immune Evading Stealth Cell for Relapsed/Refractory Non-Hodgkin Lymphoma